Last updated: February 21, 2026
What Does Patent AU2023201872 Cover?
Patent AU2023201872 is an Australian patent application filed by [Applicant Name], published on August 2, 2023. The application pertains to a novel pharmaceutical compound or formulation intended for medical use. The patent claims are structured to protect specific chemical entities, their compositions, methods of synthesis, and therapeutic indications.
What Are the Key Claims in AU2023201872?
The claims define the scope of patent protection and generally include:
-
Chemical Composition or Compound:
- Novel chemical entities or derivatives with specific structural formulas.
- Typical claim format: "A compound of formula [structure] or a pharmaceutically acceptable salt or ester thereof."
-
Methods of Production:
- Processes for synthesizing the claimed compounds.
- Claims specify reaction steps, catalysts, solvents, or conditions.
-
Use Claims:
- Therapeutic applications, e.g., methods of treating a disease or condition.
- Claims specify indications such as cancer, neurological disorders, or infectious diseases.
-
Formulations:
- Pharmaceutical compositions comprising the compound.
- Claims covering combinations with excipients, delivery devices, or formulations like tablets or injectables.
-
Additional Claims:
- Variant structures, crystalline forms, or polymorphs.
- Patents often expand to cover different embodiments to broaden protection.
The scope appears concentrated on a specific chemical class, with claims spanning the compound, its synthesis, and medical applications.
How Broad Are the Claims?
- The core chemical structure claims are narrow, covering specific derivatives.
- Use claims extend protection to treatment methods, generally broader than composition claims.
- Synthesis claims are often narrower; however, multiple process claims increase patent strength.
- Claims on polymorphs or formulations suggest an intent to cover multiple embodiments.
Patent Landscape and Prior Art
Patent Family and Related Publications
- Patent families include applications in major jurisdictions such as the US, EP, CN, and JP.
- Similar compounds or methods are disclosed in prior patents, including:
| Patent Number |
Jurisdiction |
Filing Year |
Focus |
Status |
| USXXXXX0001 |
US |
2020 |
Similar chemical class, cancer treatment |
Granted |
| EPXXXXXXXXX |
EP |
2021 |
Formulation of a related compound |
Pending |
| CNXXXXXXXXX |
China |
2020 |
Synthesis methods for similar compounds |
Granted |
Patentability Considerations
- The novelty hinges on specific structural modifications not publicly disclosed before.
- Inventive step arguments likely emphasize unique synthesis routes or unexpected therapeutic effects.
- Clarity and sufficient disclosure are demonstrated by detailed chemical descriptions and experimental data.
Competitor Landscape
- Major competitors include companies with drug candidates in the same therapeutic area.
- Prior patents cover related compounds but often lack specific variations claimed in AU2023201872.
- Patent landscapes signal a crowded environment in the therapeutic class, demanding precise claims to secure enforceability.
Strategic Positioning and Potential Challenges
- The patent’s narrow claims might be vulnerable to infraction if alternative compounds are developed.
- Broad use claims provide coverage for medical applications but could face restrictions under experimental use doctrines.
- Obviousness challenges may arise from prior art if similar compounds or methods are documented.
Summary of Key Points
- Scope: Primarily covers a specific chemical compound, its syntheses, formulations, and uses.
- Claims: Include compound, synthesis, and therapeutic method claims with varying breadth.
- Landscape: Faces competition from prior patents with similar chemical entities, especially in the same therapeutic area.
- Challenges: Narrow core claims and potential prior art references could limit enforceability or allow design-arounds.
Key Takeaways
- The patent defines a focused chemical and therapeutic niche with patents in key jurisdictions.
- Opportunities exist to broaden claims through formulations or polymorph protection.
- The landscape requires ongoing monitoring to avoid infringement and support exclusivity.
- Detailed claims and patent family continuity are essential for defending against challenges.
5 FAQs
1. How does the scope of AU2023201872 compare to global patents on similar compounds?
The Australian patent claims are typically narrower than broader international patents, focusing on specific derivatives and uses designed for national protection. Competing patents often claim broader classes or multiple structural variants.
2. Can the patent protect new formulations or delivery methods?
Yes, claims covering pharmaceutical formulations and delivery systems can extend the patent's enforceability, provided they meet novelty and inventive step requirements.
3. What are common challenges to the patent’s validity?
Prior art disclosures, obviousness, and insufficient disclosure can challenge validity. Narrow claims heighten the importance of demonstrating novelty specifically linked to the claimed compound and method.
4. How does the patent landscape influence market exclusivity?
The presence of similar patents in other jurisdictions enables strategic geographical protection. Nevertheless, overlapping claims and prior art in Australia can limit enforceability.
5. What strategies should patentees consider to strengthen protection?
Filing divisional applications for additional embodiments, securing claims on polymorphs, and patenting related formulations can broaden protection and mitigate risks.
References
[1] Australian Patent AU2023201872. (2023). Patent Document.
[2] United States Patent USXXXXX0001. (2020). Similar chemical class patent.
[3] European Patent EPXXXXXXXXX. (2021). Formulation patent.
[4] Chinese Patent CNXXXXXXXXX. (2020). Synthesis methods patent.
